Stage I Nasopharyngeal Undifferentiated Carcinoma AJCC v7
specificStage II includes: (T1, N1, M0); (T2, N0, M0); (T2, N1, M0). T1: Nasopharyngeal cancer with tumor confined to the nasopharynx, or tumor extending to oropharynx and/or nasal cavity without parapharyngeal extension. Parapharyngeal extension denotes posterolateral infiltration of tumor. T2: Nasopharyngeal cancer with parapharyngeal extension. Parapharyngeal extension denotes posterolateral infiltration of tumor. N0: No regional lymph node metastasis. N1: Nasopharyngeal cancer with unilateral me
35
Centers
0
Active Trials
—
Cancer Funding
Top Centers for Stage I Nasopharyngeal Undifferentiated Carcinoma AJCC v7(35)
Ranked by research excellence score (trials · grants · publications). Methodology →
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →